Biotechnology News

SOUTH SAN FRANCISCO, Calif., Aug. 2, 2007 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Fred Vitale, Vice...

Focus Area: New and Emerging Therapeutic Targets for CNS Topic: SP-233: A New and Novel Therapy With Protective Properties Against the Neurotoxic Effects of Beta-Amyloid Peptide LAS VEGAS,...

TEMPE, Ariz., Aug. 2, 2007 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) today announced the formation of a Scientific Advisory Board (SAB) with the appointments of Michael E. Mendelsohn, M.D. of...

TEMPE, Ariz., Aug. 2, 2007 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today that it will release financial and operating results for the second quarter ending June 30, 2007, on...

BERKELEY, Calif., Aug. 2, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that David Boyle, XOMA's Chief Financial Officer, is scheduled to present at the Canaccord Adams Global...

WARRINGTON, Pa., Aug. 2, 2007 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), today announced financial results for the second quarter ended June 30, 2007. The Company will host a...

WARRINGTON, Pa., Aug. 2, 2007 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today reports progress in addressing previously-announced manufacturing and stability issues and the April...

CARLSBAD, Calif., Aug. 2, 2007 (PRIME NEWSWIRE) -- Isis Pharmaceuticals, Inc. (Nasdaq:ISIS) announces the following webcast: What: Isis Pharmaceuticals' Second Quarter 2007 Financial ...

Genmab får rettighederne til HuMax-TAC tilbage Resumé: Genmab har fået alle rettigheder til HuMax-TAC tilbage fra Merck Serono S.A. ...

Genmab regains rights to HuMax-TAC Summary: Genmab has regained all rights to HuMax-TAC from Merck Serono S.A. Copenhagen, Denmark; August 2,...